Assignee
OLON SPA
IT·22 granted patents·21 pending applications·8 citations·filing 2013–2023
Top patents by PatentIndex Score
43 records- 0180US10329311B1Process for the preparation of crisaboroleOLON SPA·Filed 2018·Granted Jun 25, 2019·2 cites·14 claims
- 0275US9981951B2Crystalline and amorphous forms of OlaparibOLON SPA·Filed 2016·Granted May 29, 2018·3 cites·1 claims
- 0369US9340571B2Process for the purification of abiraterone acetateOLON SPA·Filed 2013·Granted May 17, 2016·1 cites·8 claims
- 0468US9828380B2Efficient method for the preparation of tofacitinib citrateOLON SPA·Filed 2016·Granted Nov 28, 2017·1 cites·9 claims
- 0567US11325922B2Process for the preparation of Crisaborole in a stable crystal formOLON SPA·Filed 2020·Granted May 10, 2022·0 cites·8 claims
- 0662US9630987B2Procedure for the preparation of abiraterone acetate and intermediates thereofOLON SPA·Filed 2016·Granted Apr 25, 2017·0 cites·1 claims
- 0759US9045515B2Procedure for the purification of tiacumicin BOLON SPA·Filed 2013·Granted Jun 2, 2015·1 cites·10 claims
- 0859US2025276974A1Process for preparing zanubrutinib in amorphous formOLON SPA·Filed 2023·Application pending·0 cites
- 0956US9556219B2Procedure for the preparation of abiraterone acetate and intermediates thereofOLON SPA·Filed 2015·Granted Jan 31, 2017·0 cites·14 claims
- 1056US2021070781A1A process for the preparation of crisaboroleOLON SPA·Filed 2018·Application pending·0 cites
- 1154US11053227B2Process for preparing intermediates for the synthesis of optically active beta-amino alcohols by enzymatic reduction and novel synthesis intermediatesOLON SPA·Filed 2018·Granted Jul 6, 2021·0 cites·5 claims
- 1254US2024059696A1Process for preparing high purity degree larotrectinibOLON SPA·Filed 2022·Application pending·0 cites
- 1354US2025197419A1Purification processes of rifampicin from nitrosaminesOLON SPA·Filed 2023·Application pending·0 cites
- 1452US9975832B2Process for the preparation of ospemifene and fispemifeneOLON SPA·Filed 2015·Granted May 22, 2018·0 cites·1 claims
- 1550US10035776B2Process for the preparation of enzalutamideOLON SPA·Filed 2016·Granted Jul 31, 2018·0 cites·5 claims
- 1650US2023322658A1Process for the preparation of a key intermediate of siponimodOLON SPA·Filed 2021·Application pending·0 cites
- 1750US2023098051A1Process for the preparation of lasmiditan and of a synthesis intermediateOLON SPA·Filed 2020·Application pending·0 cites
- 1849US11028082B2Process for the preparation of a novel umeclidinium synthesis intermediateOLON SPA·Filed 2018·Granted Jun 8, 2021·0 cites·14 claims
- 1948US10538479B2Process for the preparation of indanamine derivatives and new synthesis intermediatesOLON SPA·Filed 2016·Granted Jan 21, 2020·0 cites·15 claims
- 2048US2026000577A1Methods and assemblies for control of formation of nitrosamine impurities in solid active pharmaceutical ingredientsOLON SPA·Filed 2023·Application pending·0 cites
- 2147US11498917B2Process for the preparation of lifitegrastOLON SPA·Filed 2019·Granted Nov 15, 2022·0 cites·15 claims
- 2247US9809554B2Process for preparing ivabradineOLON SPA·Filed 2014·Granted Nov 7, 2017·0 cites·9 claims
- 2347US2024150282A1Novel crystalline compound of siponimod hemifumarateOLON SPA·Filed 2021·Application pending·0 cites
- 2447US2024425510A1Process for the preparation of zanubrutinibOLON SPA·Filed 2022·Application pending·0 cites
- 2546US11319288B2Method for the preparation of pimavanserin baseOLON SPA·Filed 2019·Granted May 3, 2022·0 cites·8 claims
- 2646US9315541B2Process for the preparation of unsaturated trifluoromethanesulfonate steroid derivativesOLON SPA·Filed 2015·Granted Apr 19, 2016·0 cites·8 claims
- 2742US9862740B2Process for preparing novel forms of tiacumicin BOLON SPA·Filed 2014·Granted Jan 9, 2018·0 cites·11 claims
- 2842US2021061757A1Process for the synthesis of optically active beta-amino alcoholsOLON SPA·Filed 2019·Application pending·0 cites
- 2938US11279724B2Efficient method for the preparation of CangrelorOLON SPA·Filed 2018·Granted Mar 22, 2022·0 cites·20 claims
- 3038US10487070B2Process for preparing intermediates useful in the synthesis of antifungal drugsOLON SPA·Filed 2017·Granted Nov 26, 2019·0 cites·10 claims
- 3138US9970041B2Procedure for the production of tiacumicin BOLON SPA·Filed 2013·Granted May 15, 2018·0 cites·10 claims
- 3238US2022153718A1Synthesis of stable amorphous apalutamideOLON SPA·Filed 2020·Application pending·0 cites
- 3337US11820752B2Process for the preparation of apalutamideOLON SPA·Filed 2019·Granted Nov 21, 2023·0 cites·6 claims
- 3437US2020407355A1Crystalline forms of venetoclaxOLON SPA·Filed 2019·Application pending·0 cites
- 3536US2022324831A1Stable crystalline apalutamide in pure form, and process for the preparation thereofOLON SPA·Filed 2020·Application pending·0 cites
- 3634US2013266986A1Procedure for the production of tiacumicin bOLON SPA·Filed 2013·Application pending·0 cites
- 3733US2018148416A1Industrial process for the preparation of enzalutamideOLON SPA·Filed 2016·Application pending·0 cites
- 3833US2017165247A1Crystalline compounds of dabigatran etexilateOLON SPA·Filed 2015·Application pending·0 cites
- 3933US2021171464A1Amorphous form of pimavanserin hemitartrateOLON SPA·Filed 2018·Application pending·0 cites
- 4032US2018222909A1Process for the preparation of ibrutinib and new synthesis intermediateOLON SPA·Filed 2016·Application pending·0 cites
- 4132US2018282339A1Process for the preparation of the amorphous form of ibrutinib and novel crystalline formOLON SPA·Filed 2016·Application pending·0 cites
- 4228US2019276399A1Polymorph of nintedanibOLON SPA·Filed 2017·Application pending·0 cites
- 4327US2017158645A1Amorphous form and new crystalline forms of macitentanOLON SPA·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when OLON SPA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →